Nuo Therapeutics, Inc. (AURX)

EBITDA

-$120.95K

Quarterly · Period ending: · USD

AURX logo

AURX EBITDA

Latest reported-$120.95K
AURX Quarterly EBITDA (-$6.48M → -$120.95K)
High-resolution chart · PNG

AURX ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Nuo Therapeutics, Inc. EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
-120,952
-405,268
-536,928
-496,289
-611,312
-715,125
-600,853
-556,907
-522,084
-681,722
-625,107
-764,248
-845,406
-829,345
-934,615
-888,025
-902,823
-370,091
0
0
0
0
-144,082
16,211
89,558
-29,500
-357,006
-586,628
182,685
-606,621
-563,754
-641,642
-7,752,294
-1,082,995
-3,642,846
-1,374,826
-1,994,629
-1,606,404
-1,688,636
-4,456,043
-3,485,693
-3,330,934
-4,260,288
-3,201,776
-4,419,169
-4,454,724
-4,917,764
-4,432,487
-3,603,533
-4,355,257
-4,373,874
-3,664,104
-9,124,447
-3,196,394
-6,888,643
-4,227,220
1,348,106
-875,626
-1,237,978
-1,482,727
-1,333,296
-1,114,024
-1,426,125
-1,060,706
-1,084,751
-558,356
-881,703
-891,248
-1,137,549
-860,702
-1,254,605
-927,226
-1,117,723
-2,579,998
-667,699
-862,869
-956,390
-712,155
-915,720
-749,942
-977,324
-1,220,030
-1,616,975
-1,425,878
-1,353,267
-1,287,294
-1,262,582
-969,007
-1,355,327
-993,053
-1,106,710
-676,614
-793,167
-856,892
-537,553
-440,069
-368,847
-119,385
-2,122,775
-2,164,802
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.